TT  UPMC Enterprises

https://enterprises.upmc.com/





     Office Locations:

6425 Penn Ave, Suite 200
Pittsburgh, PA 15206
Phone: 412-647-8762

 

Stages:

  • Early
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    UPMC Enterprises is the commercialization arm of UPMC, a Pittsburgh-based health care provider and insurer. UPMC Enterprises, both develops and invests in exceptional health care technology. A $20 billion health care provider and insurer, Pittsburgh-based UPMC is inventing new models of patient-centered, cost-effective, accountable care. The largest nongovernmental employer in Pennsylvania, UPMC integrates 89,000 employees, 40 hospitals, 700 doctors' offices and outpatient sites, and a nearly 3.6 million-member Insurance Services Division, the largest medical insurer in western Pennsylvania. The UPMC Enterprises' Translational Sciences team has committed to investing $800 million by 2024 to find treatments and cures for a wide variety of diseases included $200 million previously committed to form the UPMC Immune Transplant and Therapy Center (ITTC).



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Adam Berger CTO
    Brent Burns Executive Vice President
    Jeanne Cunicelli Executive Vice President
    Mark Stabingas Executive Vice President
    Tal Heppenstall Executive Vice President

     

    Portfolio companies include:


      Alung Technologies
        web link


      Health Catalyst
        web link


      Omicia
        web link


      Werewolf Therapeutics
        web link


      Xealth
        web link


     

    Recent News: